PHARMExcel is delighted to celebrate the achievements of its Founder and CEO, Yvanne Enever, who has been nominated Businesswoman of the Year at the SME Hertfordshire Business Awards 2022.
PHARMExcel is proud to be shortlisted to win Business of the Year 2022 at the SME Hertfordshire Business Awards. The award recognises innovation, commercial boldness and outstanding management practices.
How to support employee mental health and create a happy and productive team. PHARMExcel explores new well-being initiatives for office and remote workers.
The process of taking a pharmaceutical drug through its drug discovery pathway can be challenging, time consuming, and expensive. It’s why more and more leading biotech and pharma companies choose to outsource clinical research work to contract research organisations (CROs) instead.
This month PHARMExcel reaches yet another milestone as it celebrates 13 years of successful business.
This programme, (supported by CEPI funding), will provide the infrastructure to help design and select the lead antigen through proof-of-concept preclinical studies, progressing to initial clinical development through Phase I/II studies. DIOSynVax aim to establish clinical proof of concept for a novel vaccine candidate with the potential to provide broad protection against Sarbecovirus, Merbecovirus, Embecovirus and Nobecovirus.
Following its reputation of excellence in delivering investigator-led studies, PHARMExcel was selected to manage the Covid-19 vaccine booster study.
